Literature DB >> 19732767

Knockdown of human deubiquitinase PSMD14 induces cell cycle arrest and senescence.

Ann Byrne1, Rajashree P McLaren, Paul Mason, Lilly Chai, Michael R Dufault, Yinyin Huang, Beirong Liang, Joseph D Gans, Mindy Zhang, Kara Carter, Tatiana B Gladysheva, Beverly A Teicher, Hans-Peter N Biemann, Michael Booker, Mark A Goldberg, Katherine W Klinger, James Lillie, Stephen L Madden, Yide Jiang.   

Abstract

The PSMD14 (POH1, also known as Rpn11/MPR1/S13/CepP1) protein within the 19S complex (19S cap; PA700) is responsible for substrate deubiquitination during proteasomal degradation. The role of PSMD14 in cell proliferation and senescence was explored using siRNA knockdown in carcinoma cell lines. Our results reveal that down-regulation of PSMD14 by siRNA transfection had a considerable impact on cell viability causing cell arrest in the G0-G1 phase, ultimately leading to senescence. The molecular events associated with decreased cell proliferation, cell cycle arrest and senescence include down-regulation of cyclin B1-CDK1-CDC25C, down-regulation of cyclin D1 and up-regulation of p21(/Cip) and p27(/Kip1). Most notably, phosphorylation of the retinoblastoma protein was markedly reduced in PSMD14 knockdown cells. A comparative study with PSMB5, a subunit of the 20S proteasome, revealed that PSMB5 and PSMD14 have different effects on cell cycle, senescence and associated molecular events. These data support the view that the 19S and 20S subunits of the proteasome have distinct biological functions and imply that targeting 19S and 20S would have distinct molecular consequences on tumor cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732767     DOI: 10.1016/j.yexcr.2009.08.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  22 in total

1.  PAC1 gene knockout reveals an essential role of chaperone-mediated 20S proteasome biogenesis and latent 20S proteasomes in cellular homeostasis.

Authors:  Katsuhiro Sasaki; Jun Hamazaki; Masato Koike; Yuko Hirano; Masaaki Komatsu; Yasuo Uchiyama; Keiji Tanaka; Shigeo Murata
Journal:  Mol Cell Biol       Date:  2010-05-24       Impact factor: 4.272

2.  A mosaic 2q24.2 deletion narrows the critical region to a 0.4 Mb interval that includes TBR1, TANK, and PSMD14.

Authors:  Lindsay C Burrage; Tanya N Eble; Patricia M Hixson; Erin K Roney; Sau W Cheung; Luis M Franco
Journal:  Am J Med Genet A       Date:  2013-02-26       Impact factor: 2.802

Review 3.  Meddling with Fate: The Proteasomal Deubiquitinating Enzymes.

Authors:  Stefanie A H de Poot; Geng Tian; Daniel Finley
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

4.  Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis.

Authors:  Joseph U Igietseme; Yusuf Omosun; Olga Stuchlik; Matthew S Reed; James Partin; Qing He; Kahaliah Joseph; Debra Ellerson; Brigid Bollweg; Zenas George; Francis O Eko; Claudiu Bandea; Hsi Liu; Genyan Yang; Wun-Ju Shieh; Jan Pohl; Kevin Karem; Carolyn M Black
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

5.  Base-CP proteasome can serve as a platform for stepwise lid formation.

Authors:  Zanlin Yu; Nurit Livnat-Levanon; Oded Kleifeld; Wissam Mansour; Mark A Nakasone; Carlos A Castaneda; Emma K Dixon; David Fushman; Noa Reis; Elah Pick; Michael H Glickman
Journal:  Biosci Rep       Date:  2015-01-27       Impact factor: 3.840

6.  NSun2 delays replicative senescence by repressing p27 (KIP1) translation and elevating CDK1 translation.

Authors:  Hao Tang; Xiuqin Fan; Junyue Xing; Zhenyun Liu; Bin Jiang; Yali Dou; Myriam Gorospe; Wengong Wang
Journal:  Aging (Albany NY)       Date:  2015-12       Impact factor: 5.682

7.  POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation.

Authors:  Boshi Wang; Aihui Ma; Li Zhang; Wei-Lin Jin; Yu Qian; Guiqin Xu; Bijun Qiu; Zhaojuan Yang; Yun Liu; Qiang Xia; Yongzhong Liu
Journal:  Nat Commun       Date:  2015-10-29       Impact factor: 14.919

8.  The proteasomal de-ubiquitinating enzyme POH1 promotes the double-strand DNA break response.

Authors:  Laura R Butler; Ruth M Densham; Junying Jia; Alexander J Garvin; Helen R Stone; Vandna Shah; Daniel Weekes; Frederic Festy; James Beesley; Joanna R Morris
Journal:  EMBO J       Date:  2012-08-21       Impact factor: 11.598

9.  Sequencing of a patient with balanced chromosome abnormalities and neurodevelopmental disease identifies disruption of multiple high risk loci by structural variation.

Authors:  Jonathon Blake; Andrew Riddell; Susanne Theiss; Alexis Perez Gonzalez; Bettina Haase; Anna Jauch; Johannes W G Janssen; David Ibberson; Dinko Pavlinic; Ute Moog; Vladimir Benes; Heiko Runz
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.

Authors:  A Linton; Y Y Cheng; K Griggs; Lyn Schedlich; M B Kirschner; S Gattani; S Srikaran; S Chuan-Hao Kao; B C McCaughan; S Klebe; N van Zandwijk; G Reid
Journal:  Br J Cancer       Date:  2013-12-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.